| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10285), 1637, 2021 | 2186* | 2021 |
| Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort DT Arnold, FW Hamilton, A Milne, AJ Morley, J Viner, M Attwood, A Noel, ... Thorax 76 (4), 399-401, 2021 | 741 | 2021 |
| Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study RA Evans, HJC McAuley, EM Harrison, A Shikotra, A Singapuri, M Sereno, ... The Lancet Respiratory Medicine 9 (11), 1275-1287, 2021 | 558 | 2021 |
| Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group, PW Horby, M Mafham, L Peto, ... Medrxiv, 2021.06. 15.21258542, 2021 | 517* | 2021 |
| Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study RA Evans, OC Leavy, M Richardson, O Elneima, HJC McAuley, ... The Lancet Respiratory Medicine 10 (8), 761-775, 2022 | 350 | 2022 |
| Effect of noninvasive respiratory strategies on intubation or mortality among patients with acute hypoxemic respiratory failure and COVID-19: the RECOVERY-RS randomized … GD Perkins, C Ji, BA Connolly, K Couper, R Lall, JK Baillie, JM Bradley, ... Jama 327 (6), 546-558, 2022 | 343 | 2022 |
| Bronchoscopic lung-volume reduction with Exhale airway stents for emphysema (EASE trial): randomised, sham-controlled, multicentre trial PL Shah, DJ Slebos, PFG Cardoso, E Cetti, K Voelker, B Levine, ... The Lancet 378 (9795), 997-1005, 2011 | 294 | 2011 |
| Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet 400 (10349), 359-368, 2022 | 272 | 2022 |
| Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis CJ Stock, H Sato, C Fonseca, WAS Banya, PL Molyneaux, H Adamali, ... Thorax 68 (5), 436-441, 2013 | 243 | 2013 |
| Outcome of hospitalization for COVID-19 in patients with interstitial lung disease. An international multicenter study TM Drake, AB Docherty, EM Harrison, JK Quint, H Adamali, S Agnew, ... American journal of respiratory and critical care medicine 202 (12), 1656-1665, 2020 | 231 | 2020 |
| Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 399 (10325), 665, 2022 | 226 | 2022 |
| Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trial D Visca, L Mori, V Tsipouri, S Fleming, A Firouzi, M Bonini, MJ Pavitt, ... The Lancet Respiratory Medicine 6 (10), 759-770, 2018 | 208 | 2018 |
| Daily home spirometry: an effective tool for detecting progression in idiopathic pulmonary fibrosis AM Russell, H Adamali, PL Molyneaux, PT Lukey, RP Marshall, ... American journal of respiratory and critical care medicine 194 (8), 989-997, 2016 | 191 | 2016 |
| Acute exacerbations and pulmonary hypertension in advanced idiopathic pulmonary fibrosis EP Judge, A Fabre, HI Adamali, JJ Egan European Respiratory Journal 40 (1), 93-100, 2012 | 174 | 2012 |
| Use of transbronchial cryobiopsy in the diagnosis of interstitial lung disease—a systematic review and cost analysis C Sharp, M McCabe, H Adamali, AR Medford QJM: An International Journal of Medicine 110 (4), 207-214, 2017 | 145 | 2017 |
| Apical and narrow cells are distinct cell types differing in their structure, distribution, and functions in the adult rat epididymis HI ADAMALI, L HERMO Journal of andrology 17 (3), 208-222, 1996 | 137 | 1996 |
| Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled … JJ Solomon, SK Danoff, FA Woodhead, S Hurwitz, R Maurer, I Glaspole, ... The Lancet Respiratory Medicine 11 (1), 87-96, 2023 | 117 | 2023 |
| Current and novel drug therapies for idiopathic pulmonary fibrosis MTM Adamali HI Drug Design, Development and Therapy 6, 261–272, 2012 | 102 | 2012 |
| Rituximab in autoimmune connective tissue disease–associated interstitial lung disease C Sharp, M McCabe, N Dodds, A Edey, L Mayers, H Adamali, AB Millar, ... Rheumatology 55 (7), 1318-1324, 2016 | 98 | 2016 |
| Immunolocalization of CA II and H+V‐ATPase in Epithelial Cells of the Mouse and Rat Epididymis L HERMO, HI ADAMALI, S ANDONIAN Journal of andrology 21 (3), 376-391, 2000 | 97 | 2000 |
